In particular, Fenretinide has been reported to eliminate ABT-737-resistant cell lines via ROS generation and MCL1 reduction and thus has synergetic effect with ABT-737 to enhance mitochondrial apoptotic cascade in acute lymphoblastic leukemia (ALL) [271]. This evidence concerns the gene MCL1 and acute lymphoblastic leukemia.